MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-06-0004071
I G Pharma Limited
I G Pharma Limited - pharma in Roorkee, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹18.98 Cr
▲ 7% YoY
Net profit · FY 2025
₹14.02 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹1.37 Cr
EBITDA margin 7.2%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹48.3 Lakh
Issued & subscribed
Open charges
₹7.26 Cr
Satisfied ₹16.6 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
24
Provident fund records
About I G Pharma Limited
Data last updated:
I G Pharma Limited is a public limited company based in Roorkee, Uttarakhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24232UR2005PLC011213. Its GSTIN is 05AABCI5336D1Z0 (Uttarakhand). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹48.3 Lakh. It is led by directors including Krishana Devi and Ashok Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 12.4 Km Meerut Road Roorkee Libberheri, Uttarakhand, India – 247667.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.98 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹14.02 Lakh (net margin 0.7%) and EBITDA of ₹1.37 Cr (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 6% over five years.
The company has about 24 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹7.26 Cr and satisfied charges of ₹16.6 Cr on record. Court records list 20 cases involving the company, including 7 filed by the company and 13 filed against it; 12 cases are pending.
I G Pharma Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0004071). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232UR2005PLC011213
Registration Number 011213
Incorporation Date 14 June 2005
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-06-0004071
CIN history
I G Pharma has one previous CIN (Corporate Identification Number): U24232DL2005PLC137560. The current CIN is U24232UR2005PLC011213, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232UR2005PLC011213 | Current |
| U24232DL2005PLC137560 | Previous |
Recognitions & Rankings of I G Pharma
Contact details
I G Pharma Limited's registered office is in Roorkee, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address12.4 Km Meerut Road Roorkee Libberheri, Uttarakhand, India – 247667
- IndustryPharma, Drug Formulation & Development
To see the full contact details of I G Pharma Limited, buy the company report.
Comprehensive company report
I G Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of I G Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of I G Pharma Limited, buy the company report.
Financials of I G Pharma Limited
FY 2024 filings availableI G Pharma Limited reported revenue of ₹18.98 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹18.98 Cr ▲ 7%
Net profit · FY 2025
₹14.02 Lakh margin 0.7%
EBITDA · FY 2025
₹1.37 Cr margin 7.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 15%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 13%
5 years · compounded
▲ 8%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 7% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.37 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of I G Pharma Limited, buy the company report.
Board of directors of I G Pharma Limited
I G Pharma has 3 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishana Devi | Director | 03 Sep 2021 | 5 Years 1 Months | Current |
| Ashok Kumar | Director | 12 Jun 2024 | 2 Years 4 Months | Current |
| Vikram Chugh Also directs: Bullford World Limited | Director | 03 Nov 2012 | 13 Years 11 Months | Current |
Peer comparison
I G Pharma Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Omega Biotech Limited | ₹19.07 Cr (FY 2024) | 10.0% | New Delhi, Delhi, India | |||
| Maha Avtar Health Care Private Limited | ₹19.06 Cr (FY 2025) | 43.0% | Delhi, India | |||
| I G Pharma Limitedthis company | ₹18.98 Cr (FY 2025) | ₹14.02 Lakh | 0.7% | 7.0% | 24 | Roorkee, Uttarakhand, India |
| Vanguard Therapeutics Private Limited | ₹18.98 Cr (FY 2025) | -19.0% | Telangana, India | |||
| Vasudha Life Science Private Limited | ₹18.95 Cr (FY 2025) | 27.0% | Brahmavara, Karnataka, India | |||
| Isera Biological Limited | ₹18.94 Cr (FY 2025) | 83.0% | Pune, Maharashtra, India |
To see the full peer comparison of I G Pharma Limited, buy the company report.
Auditor
I G Pharma Limited is audited by P. S. SETHI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P. S. SETHI & CO. | FY 2023 | 004545C |
Shareholding
The shareholding of I G Pharma Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of I G Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹7.26 Cr
Satisfied charges
₹16.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jul 2024 | 100954506 | Hdfc Bank Limited | ₹5.99 Cr | Open | |
| 11 Sep 2023 | 100775161 | Sidbi | ₹1 Cr | Open | |
| 26 Jun 2020 | 100350992 | Others | ₹6.5 Lakh | Open | |
| 23 Jun 2020 | 100350994 | Others | ₹6.8 Lakh | Open | |
| 15 Oct 2016 | 100069032 | Dena Bank | ₹14 Lakh | Open |
To see the full charge records of I G Pharma Limited, buy the company report.
Total charge records: 14 View all charges
Legal cases
I G Pharma Limited has 20 court cases on record: 7 filed by I G Pharma, 13 filed against it. 12 cases are pending and 8 are disposed.
Total cases
20
Filed by the company
7
Filed against the company
13
Pending
12
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 8 | 7 |
| High courts | 7 | 5 | 5 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (CSTAY) | Filed by the company against M/S Parth Formulation Pvt. Ltd. | Pending |
| High Court | Appeal | Filed by the company against M/S Parth Formulation Pvt. Ltd. | Pending |
| High Court, MAHARASHTRA | Court case (NMCD) | Filed against the company by Wockhardt Limited | Pending |
| District court, Central, Delhi | Court case (Contempt Petition) | Filed against the company by M/S Laborate Pharmaceuticals India Ltd | Disposed |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against Brown and Black Bio Pvt.Ltd and Ors | Disposed |
To see the full case history of I G Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for I G Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
I G Pharma Limited has a workforce of 24 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
24
Active EPFO establishments
1
Employee growth
-33.33%
GST
I G Pharma has 4 GST registrations: 3 active and 1 cancelled or inactive.
Total GSTINs
4
Active
3
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AABCI5336D1Z0 | Uttarakhand | Active | 01 Jul 2017 |
| 08AABCI5336D2ZT | Rajasthan | Active | 13 Mar 2023 |
| 23AABCI5336D1Z2 | Madhya Pradesh | Active | 01 Sep 2023 |
To see the full GST registrations and return filing status of I G Pharma Limited, buy the company report.
Recent activity
I G Pharma Limited has 15 board changes on record since 2011: 3 appointments and 12 cessations. The latest: Ashok Kumar ceased to be Additional Director on 29 Sep 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 599.00 Lakh registered on 10 Jul 2024 with Charge ID 100954506 was modified on 24 Apr 2025.
AGM
I G Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Ashok Kumar ceased to be Additional Director.
Charges
A charge registered on 09 Mar 2022 via Charge ID 100555101 with Axis Bank Limited was fully satisfied on 02 Sep 2024.
Charges
A charge registered on 09 Mar 2022 via Charge ID 100549662 with Axis Bank Limited was fully satisfied on 02 Sep 2024.
Charges
A charge registered on 09 Mar 2022 via Charge ID 100549654 with Axis Bank Limited was fully satisfied on 02 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 599.00 Lakh with Charge ID 100954506 was registered on 10 Jul 2024.
Ceased
Vipin Kukkar ceased to be Director.
Appointed
Ashok Kumar was appointed as Director.
Filing
I G Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand.
Charges
A charge with Sidbi amounted to Rs. 100.00 Lakh with Charge ID 100775161 was registered on 11 Sep 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 179.00 Lakh with Charge ID 100555101 was registered on 09 Mar 2022.
30 earlier events are in the company report.
Frequently asked questions
I G Pharma is an active public limited company based in Roorkee, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2005 (21+ years old) and is registered under CIN U24232UR2005PLC011213.
I G Pharma has 3 current directors:
- Krishana Devi - Director
- Ashok Kumar - Director
- Vikram Chugh - Director
The latest financial statements of I G Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of I G Pharma is 05AABCI5336D1Z0, registered in Uttarakhand. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 08AABCI5336D2ZT (Rajasthan), 23AABCI5336D1Z2 (Madhya Pradesh).
The CIN (Corporate Identification Number) of I G Pharma is U24232UR2005PLC011213. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
I G Pharma has 20 court cases on record: 7 filed by the company and 13 filed against it. 12 are pending. Most are in the district courts.
I G Pharma was incorporated on 14 June 2005, making it 21+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of I G Pharma by revenue are Omega Biotech Limited, Maha Avtar Health Care Private Limited, Vanguard Therapeutics Private Limited, Vasudha Life Science Private Limited, Isera Biological Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashok Kumar ceased to be Additional Director on 29 Sep 2024. Vipin Kukkar ceased to be Director on 08 Jul 2024. Ashok Kumar was appointed as Director on 12 Jun 2024. I G Pharma has 15 board changes on record in total.
Yes, I G Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-UK-06-0004071).
The registered office of I G Pharma is at 12.4 Km Meerut Road Roorkee Libberheri, Uttarakhand, India – 247667.